Formula 1 has revised COVID-19 testing protocols after Lance Stroll case, says Racing Point boss Otmar Szafnauer

Canadian Stroll, 21, left the Eifel event early on Sunday, flying home to Switzerland, where he returned a positive test result on Monday.

Agence France-Presse October 22, 2020 18:46:08 IST
Formula 1 has revised COVID-19 testing protocols after Lance Stroll case, says Racing Point boss Otmar Szafnauer

File image of Otmar Szafnauer (L) and Lawrence Stroll. AFP

Formula One has revised its protocols for managing COVID-19 testing after Racing Point driver Lance Stroll fell ill at the Eifel Grand Prix, but was not tested until he returned home, team boss Otmar Szafnauer said on Friday.

Szafnauer, who claimed Stroll was suffering from a severe stomach upset that led to him missing the race at the Nurburgring, where he was replaced by Nico Hulkenberg, said new rules were being introduced after an examination of that case.

Speaking ahead of this weekend's Portuguese Grand Prix, where Hulkenberg is on stand-by in case Stroll is unfit to drive, Szafnauer said: "The world is learning and the FIA (the sport's ruling body, the International Motoring Federation) are learning, we're learning.

"The FIA now, I understand, have introduced a test you have to take 24 hours from (after) entering the paddock – that's new for everybody in the paddock.

"It's something they have changed. It's a good idea to add another test."

Canadian Stroll, 21, left the Eifel event early on Sunday, flying home to Switzerland, where he returned a positive test result on Monday.

Yet he had been unwell throughout that weekend without taking a test that resulted in proving he had the coronavirus .

Until now, all Formula One members have been required to return a negative test prior to travel and take further tests every five days.

The new in the weekend test is designed to identify anyone who develops the virus while attending an event.

Szafnauer said he was confident the new protocol, coupled with Stroll's negative test results ahead of the Portuguese race, ensured the Canadian would return.

"He had a negative test coming into this weekend. The probability of now giving a positive is low. Is it zero? I don't know, I don't know that much about it, but it's low," he said.

"Nico is here as a precaution, but I'm confident Lance will be in the car."

Szafnauer said he tests employees twice at the week and has returned six positives in more than 15,000 tests.

"We take this virus more seriously than anybody. We test all of our staff upon arrival from a Grand Prix so they have peace of mind when they go home that they didn't pick anything up.”

He also revealed that Stroll's father team owner Lawrence Stroll had tested positive, despite not attending the Russian or Eifel races.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Delhi govt asks pvt hospitals to keep reserved beds vacant; COVID death rate to come down in 2-3 weeks, says Jain
India

Delhi govt asks pvt hospitals to keep reserved beds vacant; COVID death rate to come down in 2-3 weeks, says Jain

At least five persons died due to COVID-19 every hour on an average in Delhi on Sunday, while the country reported an average of 21 deaths per hour in this period

Parliamentary panel red flags rapid antigen tests: A look at what makes the testing method contentious
India

Parliamentary panel red flags rapid antigen tests: A look at what makes the testing method contentious

While experts say that rapid antigen tests can help countries with out-of-control outbreaks, India’s practice of conflating the data from rapid tests and RT-PCR tests risks painting an incomplete picture of its infection rates

Feluda paper strip test for COVID-19 to be available in Indian markets by November-end
India

Feluda paper strip test for COVID-19 to be available in Indian markets by November-end

The CRISPR Feluda COVID-19 test was given approved for use by the Indian Council of Medical Research in September.